By Shelly Kumar
International Frontier Resources President and CEO Steve Hanson discusses the company’s first-mover status under Mexico’s energy reform, which is ushering in a new era in the country’s oil production.
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) announces plans for research and formulation development (“R&D”) on nonsteroidal anti-inflammatory drugs (“NSAIDs”) utilizing its patented technology and as provisioned within its previously announced 2017 & 2018 R&D program.
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) (OTCQB: LXRP) (CSE: LXX)(CSE: LXX.CN)(CNSX: LXX) (the “Company”, “Lexaria”) announces a $1 million combined research and development (“R&D”) and intellectual property (“IP”) budget.
By Jocelyn Aspa
Net Element (NASDAQ:NETE) has announced that its PayOnline subsidiary has introduced an “Instant Credit”, a feature that will allow online merchants sell goods and services on credit.
As quoted in the press release:
By integrating Instant Credit, merchants will receive the same settlement process inclusive of both bankcard and payables due from
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) welcomes the newly proposed Canadian legislation designed to allow for adult legal access to Cannabis (the “Cannabis Act”). In line with the Cannabis Act’s objective to protect public health and public safety, powerful demographic and lifestyle forces are trending away from both the harmful effects related
By Jocelyn Aspa
On April 13, the Canadian government unveiled a bill to legalize cannabis by July 1, 2018. In the US, however, laws are still a little murky.
IntelGenx in collaboration with RedHill Biopharma announced the Ministry of Health of Luxembourg has granted national marketing authorization for RIZAPORT, which treats acute migraines.
Lexaria Bioscience (OTCQB:LXRP,CSE:LXX) and NeutriSci International Inc. have completed and signed the previously announced joint venture agreement to produce and commercialize a line of healthy, sugar-free, edible cannabinoid mouth-melt products which will utilize Lexaria’s patented technology and Neutrisci’s proprietary pterostilbene tablet form factor.
By Pia Rivera
INVICTUS MD STRATEGIES CORP. (TSXV:IMH) (“Invictus MD” or the “Company”), Canada’s Cannabis Company, is pleased to provide a month in review.
March was a transformational time for Invictus MD as it worked to expand and solidify its cultivation portfolio with expansion plan forecasts of 50,000 kilograms of high quality cannabis production by
TNG Ltd. (ASX:TNG) announced that the mine site component of its flagship Mount Peake vanadium-titanium-iron project has entered into the final stages of the environmental approval process. Mount Peake is located in Australia’s Northern Territory.
Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) is pleased to announce that it has completed its previously announced brokered private placement of 4,104,280 units of the Company (“Units”) at a price per Unit of US$0.42 (the “Offering Price”), for total gross proceeds of US$1,723,798 (the “Offering”).